Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 77.34% is in line with its 3-year average of 77.79%, near the high end of its 3-year range (69.69%–79.90%).
2.14% above its 12-month average of 75.72%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 78.26%.
GROSS MARGIN
77.34%
GROSS MARGIN AVG TTM
75.72%
GROSS MARGIN AVG 3Y
77.60%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+2.14%
CURRENT VS 3Y AVG
-0.33%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+31.10%
vs the sector median at left
Shoulder Innovations, Inc.
Market Cap
$376.61M
Gross Margin
77.34%
TTM Avg
75.72%
3Y Avg
77.60%
5Y Avg
N/A
Market Cap
$45.05M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.14B
Gross Margin
73.53%
TTM Avg
70.13%
3Y Avg
70.04%
5Y Avg
68.74%
Market Cap
$1.91B
Gross Margin
49.52%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$2.99B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$5.10B
Gross Margin
49.52%
TTM Avg
48.04%
3Y Avg
46.91%
5Y Avg
45.73%
Market Cap
$5.59B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-67.67%
5Y Avg
-188.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | 77.34% | 75.72% | 77.60% | N/A |
| NRC Health (NRC)vs › | $463.35M | 56.33% | 58.27% | 60.30% | 61.48% |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | 73.53% | 70.13% | 70.04% | 68.74% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | 49.52% | 50.81% | 52.12% | 52.25% |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 58.69% | 59.64% | 63.22% | 64.62% |
| Doximity, Inc. (DOCS)vs › | $4.88B | 88.07% | 89.65% | 88.97% | 88.20% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 49.52% | 48.04% | 46.91% | 45.73% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | 0.00% | 0.00% | -67.67% | -188.00% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | 73.84% | 76.65% | 78.21% | 76.94% |
Gross Margin
77.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 78.26% |
| 2026-03-31 | 77.72% |
| 2025-12-31 | 76.70% |
| 2025-09-30 | 76.22% |
| 2025-06-30 | 69.69% |
| 2025-03-31 | 70.30% |
| 2024-12-31 | 77.57% |
| 2024-09-30 | 76.48% |
| 2024-06-30 | 76.92% |
| 2024-03-31 | 76.81% |
| 2023-12-31 | 79.46% |
| 2023-09-30 | 79.18% |
| 2023-06-30 | 78.27% |
| 2023-03-31 | 79.90% |
